Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEACE-TBI: Perampanel vs Fosphenytoin in Traumatic Brain Injury
jRCTs031250067Phase 2Recruiting
- Sponsor
- Eisai Co., Ltd.
- Start
- Jun 2025
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of perampanel in traumatic brain injury (TBI) (2 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Primary functional outcome at 90 days. Started Jun 2025; status: recruiting.
02
Drugs
perampanel
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on jRCTs031250067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031250067.